drugset / Trial / NCT02285699

The Gut Microbiota in Obsessive-Compulsive Disorder

NCT02285699 ↗

NaSingle-groupOpen-labelOther

Summary

This study will examine the gut microbiota and serum inflammatory markers in patients with Obsessive-Compulsive Disorder vs. healthy controls. Phase II of the study will examine the gut microbiota and cytokine levels following 12-weeks of treatment with Selective Serotonin Reuptake Inhibitors (SSRIs).

Timeline

Start
2014-11-01
Primary completion
2016-03-01
Completion
2016-03-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Citalopram Small molecule — —
Subject Escitalopram Small molecule — —
Subject Fluoxetine Small molecule — —
Subject Fluvoxamine Unknown — —
Subject Paroxetine Small molecule — —
Subject Sertraline Small molecule — —